UPMC Hillman Cancer Centers ( Site 0043)

Pittsburgh, Pennsylvania 15232

Use our guide to learn which trials are right for you!

We've found
2 trials
at this facility
Melanoma Clinical Trial
Safety and Efficacy of Pembrolizumab Compared to Placebo in Resected High-risk Stage II Melanoma (MK-3475-716/KEYNOTE-716)
Status: Enrolling, Phase III
Updated: 12/31/1969
UPMC Hillman Cancer Centers ( Site 0043)
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Non-Small Cell Lung Cancer Clinical Trial
Efficacy and Safety of Pembrolizumab (MK-3475) With Platinum Doublet Chemotherapy as Neoadjuvant/Adjuvant Therapy for Participants With Resectable Stage IIB or IIIA Non-small Cell Lung Cancer (MK-3475-671/KEYNOTE-671)
Status: Enrolling, Phase III
Updated: 12/31/1969
UPMC Hillman Cancer Centers ( Site 0043)
mi
from
Pittsburgh, PA
Click here to add this to my saved trials